全球MRI造影剂市场规模、份额、趋势和成长分析报告（2026-2034年）

预计 MRI造影剂市场将从 2025 年的 30.7 亿美元成长到 2034 年的 58.9 亿美元，2026 年至 2034 年的复合年增长率为 7.49%。

随着全球对先进诊断影像技术的需求不断增长，全球造影造影（MRI）造影剂市场正稳步发展。 MRI造影剂能够提高影像清晰度和准确性，有助于检测和后续观察包括癌症和神经系统疾病在内的多种疾病。慢性病发病率的上升和诊断影像检查的普及是推动市场成长的主要因素。 MRI系统的技术进步也进一步刺激了对高效能造影剂的需求。

关键成长要素包括扩大医疗保健服务覆盖范围和提升新兴经济体的诊断能力。更安全、更有效率且副作用更小的造影剂的研发，增强了病人和医生的信心。新配方获得监管部门核准以及对非钆替代品的持续研究，正在塑造创新趋势。此外，人们健康意识的提高和预防性筛检工作的发展，也促进了影像检查的成长。

展望未来，持续进行旨在提升安全性和性能的研发活动预计将惠及市场。个人化成像方法和分子成像技术的进步将创造新的机会。随着医疗机构更加重视疾病的早期检测和精准诊断，全球MRI造影剂市场预计将保持稳定成长。製药公司和影像公司之间合作的加强有望推动进一步的创新。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球MRI造影剂市场：依产品分类

• 市场分析、洞察与预测
• 顺磁性造影剂
• 超顺造影剂

第五章 全球MRI造影剂市场：依类型划分

• 市场分析、洞察与预测
• 临床
• 临床前

第六章 全球MRI造影剂市场：依应用领域划分

• 市场分析、洞察与预测
• 消化器官系统
• 静脉
• 肝胆系统
• 神经影像学
• 其他的

第七章：全球MRI造影剂市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 诊断影像中心

第八章 全球MRI造影剂市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 亚太其他地区
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • GE Healthcare
  • Bayer AG
  • Guerbet GmbH
  • Bracco Imaging SPA
  • Vitalquan LLC
  • Miltenyi Biotec BV & Co. KG
  • Lantheus Medical Imaging Inc
  • NanoPET Pharma GmbH
  • Jodas Expoim Pvt Ltd
  • Zhejiang Hisun Pharmaceutical Co. Ltd

The MRI Contrast Media Agents Market size is expected to reach USD 5.89 Billion in 2034 from USD 3.07 Billion (2025) growing at a CAGR of 7.49% during 2026-2034.

The Global MRI Contrast Media Agents Market is growing steadily as demand for advanced diagnostic imaging rises worldwide. MRI contrast agents enhance image clarity and accuracy, aiding in the detection and monitoring of various diseases, including cancer and neurological disorders. Increasing prevalence of chronic illnesses and the growing number of diagnostic imaging procedures are driving market growth. Technological advancements in MRI systems further support the need for effective contrast agents.

Key growth drivers include expanding healthcare access and improved diagnostic capabilities in emerging economies. The development of safer, more efficient contrast agents with reduced side effects has strengthened patient and physician confidence. Regulatory approvals for new formulations and continuous research into non-gadolinium-based alternatives are shaping innovation trends. Additionally, rising healthcare awareness and preventive screening initiatives contribute to increased imaging volumes.

Looking ahead, the market is expected to benefit from ongoing R&D activities aimed at enhancing safety and performance. Personalized imaging approaches and advancements in molecular imaging will create new opportunities. As healthcare providers focus on early disease detection and precision diagnostics, the Global MRI Contrast Media Agents Market is projected to maintain stable growth. Increasing collaborations between pharmaceutical and imaging companies will further drive innovation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Paramagnetic Agents
• Superparamagnetic Agents

By Type

• Clinical
• Preclinical

By Application

• Gastrointestinal
• Intravenous
• Hepatobiliary
• Neurological Imaging
• Others

By End-use

• Hospitals
• Imaging Centers

COMPANIES PROFILED

• GE Healthcare, Bayer AG, Guerbet GmbH, Bracco Imaging SpA, Vitalquan LLC, Miltenyi Biotec BV Co KG, Lantheus Medical Imaging Inc, nanoPET Pharma GmbH, Jodas Expoim Pvt Ltd, Zhejiang Hisun Pharmaceutical Co Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Paramagnetic Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Superparamagnetic Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Clinical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Preclinical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Gastrointestinal Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Intravenous Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Hepatobiliary Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Neurological Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Imaging Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Type
  • 8.2.3 By Application
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Type
  • 8.3.3 By Application
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Type
  • 8.4.3 By Application
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Type
  • 8.5.3 By Application
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Type
  • 8.6.3 By Application
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL MRI CONTRAST MEDIA AGENTS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 GE Healthcare
  • 10.2.2 Bayer AG
  • 10.2.3 Guerbet GmbH
  • 10.2.4 Bracco Imaging S.P.A
  • 10.2.5 Vitalquan LLC
  • 10.2.6 Miltenyi Biotec B.V. & Co. KG
  • 10.2.7 Lantheus Medical Imaging Inc
  • 10.2.8 NanoPET Pharma GmbH
  • 10.2.9 Jodas Expoim Pvt Ltd
  • 10.2.10 Zhejiang Hisun Pharmaceutical Co. Ltd